This event is now closed, information is displayed here for information only.

The 2017 ‘Frontiers of Oncology: Haematology’ meeting will be announced in January 2017

but you can pre-register HERE to be advised when the programme is released

 

A one day meeting to be held on
Monday 28th November 2016
The Royal College of Physicians, London, UK

PROGRAMME

---

Chairs

Professor Daniel Hochhauser Kathleen Ferrier Professor & Co-Director CRUK UCL Cancer Centre

Professor Tim Meyer Professor of Experimental Cancer Medicine UCL Cancer Institute

---

08.00	Registration & Coffee
09.00	Welcome / setting the scene: the Chairmen
	SESSION 1: Genomics and Epigenomics of Gastrointestinal Cancer
09.05	Introduction
09.10	Molecular genetics of liver cancer Professor Jessica Zucman-Rossi Professor of Medicine, Oncology Department, University Paris Descartes-HEGP; Director of the ‘Functional genomics of solid tumors’ Unit, Inserm; & Chairman of the ‘Genetic, Epigenetic and Cancer’ scientific committee, Inserm, Paris, France
09.40	Epigenetics/ Neuroendocrine cancer Dr Chrissie Thirlwell Consultant Medical Oncologist, Research Department of Oncology, UCL Cancer Institute, London, UK
10.00	Colorectal cancer & genetic heterogeneity Dr Trevor Graham Lecturer in Tumour Biology, Bart’s Cancer Institute, London, UK
10.20	Summary
10.25	Break
	SESSION 2: Novel Diagnostics in Gastrointestinal Cancer
10.55	Introduction
11.00	Circulating Tumour Cells in diagnostics/therapy Professor Tim Meyer Professor of Experimental Cancer Medicine and Consultant in Medical Oncology, Research Department of Oncology, University College London
11.20	3D Histopathology as a Novel Approach to Early Oesophageal Cancer Diagnosis Dr Marnix Jansen Physician Scientist with CRUK; Consultant histopathologist at University College London
11.40	Molecular Imaging of GI cancer Professor Tony Ng Richard Dimbleby Chair of Cancer Research, KCL Division of Cancer Studies and Randall Division; Professor of Molecular Oncology, UCL Cancer Institute, London, UK
12.00	Novel Radiological Approaches Dr Shonit Punwani Radiologist and Senior Lecturer in Clinical and Academic MRI, UCL
12.20	Summary
12.25	Lunch
	SESSION 3: New Paradigms for Trials in Gastrointestinal Cancer
13.25	Introduction
13.30	Biliary tract cancers Professor John Bridgewater Professor of Medical Oncology, Research Department of Oncology, UCL Cancer Institute, London, UK
13.50	Liver Cancer Professor Josep Llovet Professor of Research-ICREA, BCLC Group, Liver Unit, IDIBAPS-Hospital Clínic of Barcelona, Spain; Director of the HCC Research Program &Professor of Medicine, Mount Sinai School of Medicine, New York University, NY., USA
14.20	Pancreas Cancer Professor Hemant Kocher Professor of Liver & Pancreas Surgery, Bart’s Cancer Institute, London, UK
14.40	Summary
14.45	Break
	SESSION 4: Emerging Strategies for Therapy of Gastrointestinal Cancer
15.15	Introduction
15.20	Integration of conventional and novel therapies in GI cancer Professor Daniel Hochhauser Co-Director of the Cancer Research UK-UCL Centre, and Kathleen Ferrier Professor & consultant medical Oncologist, University College London
15.40	Microrna in Gastrointestinal Cancer Dr Nicola Valeri Team Leader, Gastrointestinal Cancer Biology and Genomics Team, ICR, London
16.00	Immunotherapy in GI cancer Dr Hendrik-Tobias Arkenau Executive Medical Director, Sarah Cannon Research Institute, London
16.20	Stem cells in GI (pancreas) cancer Professor Christopher Heeschen Centre Lead, Centre for Stem Cells in Cancer & Ageing, Bart’s Cancer Institute, Queen Mary University of London
16.40	Summary & Close

Costs
The meeting costs will be underwritten by Pharmaceutical Industry sponsors and the event is free of charge for healthcare professionals to attend. Places are strictly limited by room capacity.

This meeting is organised by:

 

and endorsed and supported by:

---

The Frontiers of Oncology 2019 meetings are supported by the Pharmaceutical Industry.
As support agreements are reached, disclosure of the supporters is listed here.